These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27259938)

  • 1. An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.
    Pyykkö I; Zou J; Schrott-Fischer A; Glueckert R; Kinnunen P
    Methods Mol Biol; 2016; 1427():363-415. PubMed ID: 27259938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-based delivery for the treatment of inner ear disorders.
    Pyykkö I; Zou J; Zhang W; Zhang Y
    Curr Opin Otolaryngol Head Neck Surg; 2011 Oct; 19(5):388-96. PubMed ID: 21897248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for Inner Ear Diseases: A Review of Recent
    Kim DK
    Biomed Res Int; 2017; 2017():3098230. PubMed ID: 29130038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner ear drug delivery using liposomes.
    Mohammadian F; Eatemadi A; Daraee H
    Cell Mol Biol (Noisy-le-grand); 2017 Jan; 63(1):28-33. PubMed ID: 28234628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.
    Roy S; Johnston AH; Newman TA; Glueckert R; Dudas J; Bitsche M; Corbacella E; Rieger G; Martini A; Schrott-Fischer A
    Int J Pharm; 2010 May; 390(2):214-24. PubMed ID: 20153412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear.
    Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD
    Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.
    Staecker H; Praetorius M; Brough DE
    Hear Res; 2011 Jun; 276(1-2):44-51. PubMed ID: 21251965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo studies on hydroxyapatite nanoparticles as a novel vector for inner ear gene therapy].
    Sun H; Jiang M; Zhu SH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):51-7. PubMed ID: 18357714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outlook and future of inner ear therapy.
    Devare J; Gubbels S; Raphael Y
    Hear Res; 2018 Oct; 368():127-135. PubMed ID: 29804723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intracochlear drug delivery devices in the management of inner ear disease.
    Ayoob AM; Borenstein JT
    Expert Opin Drug Deliv; 2015 Mar; 12(3):465-79. PubMed ID: 25347140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in inner ear gene therapy: exploring cochlear protection and regeneration.
    Maiorana CR; Staecker H
    Curr Opin Otolaryngol Head Neck Surg; 2005 Oct; 13(5):308-12. PubMed ID: 16160526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inner ear drug delivery: Recent advances, challenges, and perspective.
    Hao J; Li SK
    Eur J Pharm Sci; 2019 Jan; 126():82-92. PubMed ID: 29792920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and prospects of gene therapy for the inner ear.
    Sun H; Huang A; Cao S
    Hum Gene Ther; 2011 Nov; 22(11):1311-22. PubMed ID: 21338273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer in inner ear cells: a challenging race.
    Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B
    Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases.
    He Y; Chen Z; Liu Q; Li Z; Wen D; Zhang H; Zhang M; Jiang D; Li H; Wen L; Chen G
    J Control Release; 2024 Aug; 372():318-330. PubMed ID: 38906419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery for treatment of inner ear disease: current state of knowledge.
    McCall AA; Swan EE; Borenstein JT; Sewell WF; Kujawa SG; McKenna MJ
    Ear Hear; 2010 Apr; 31(2):156-65. PubMed ID: 19952751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracochlear drug delivery in combination with cochlear implants : Current aspects.
    Plontke SK; Götze G; Rahne T; Liebau A
    HNO; 2017 Jan; 65(Suppl 1):19-28. PubMed ID: 27933352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in local drug delivery to the inner ear.
    El Kechai N; Agnely F; Mamelle E; Nguyen Y; Ferrary E; Bochot A
    Int J Pharm; 2015 Oct; 494(1):83-101. PubMed ID: 26260230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of nanoparticle drug-delivery systems for the inner ear.
    An X; Zha D
    Nanomedicine (Lond); 2020 Aug; 15(20):1981-1993. PubMed ID: 32605499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.